Across TCGA pan-cancer cohorts, LINC02819 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02819’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where LINC02819 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02819 is over-expressed in tumor, although a few such as CHOL show the opposite, repressed pattern.

LIHC and CHOL are the cancer types where LINC02819 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02819 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Male	All	+0.745	<.001	4	view →
CHOL	All	All	−0.566	<.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC02819 RNA expression & survival · all LINC02819 data types